<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Metabolic syndrome and other cardiovascular risk factors associated with the progression of IgA nephropathy</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Oxford University Press (OUP)</publisher>
				<availability status="unknown"><p>Copyright Oxford University Press (OUP)</p>
				</availability>
				<date type="published" when="2012-11-02">2 November 2012</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tibor</forename><surname>Kovács</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Second Department of Medicine and Nephrological Center</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">University of Pécs</orgName>
								<address>
									<settlement>Pécs</settlement>
									<country key="HU">Hungary</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tibor</forename><surname>Vas</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Second Department of Medicine and Nephrological Center</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">University of Pécs</orgName>
								<address>
									<settlement>Pécs</settlement>
									<country key="HU">Hungary</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Csaba</forename><forename type="middle">P</forename><surname>Kovesdy</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Health Science Center</orgName>
								<orgName type="institution">University of Tennessee</orgName>
								<address>
									<settlement>Memphis</settlement>
									<region>TN</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">István</forename><surname>Késõi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Second Department of Medicine and Nephrological Center</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">University of Pécs</orgName>
								<address>
									<settlement>Pécs</settlement>
									<country key="HU">Hungary</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Balázs</forename><surname>Sági</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Second Department of Medicine and Nephrological Center</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">University of Pécs</orgName>
								<address>
									<settlement>Pécs</settlement>
									<country key="HU">Hungary</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">István</forename><surname>Wittmann</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Second Department of Medicine and Nephrological Center</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">University of Pécs</orgName>
								<address>
									<settlement>Pécs</settlement>
									<country key="HU">Hungary</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Judit</forename><surname>Nagy</surname></persName>
							<email>judit.nagy@aok.pte.hu</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Second Department of Medicine and Nephrological Center</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">University of Pécs</orgName>
								<address>
									<settlement>Pécs</settlement>
									<country key="HU">Hungary</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Metabolic syndrome and other cardiovascular risk factors associated with the progression of IgA nephropathy</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Clinical Kidney Journal</title>
						<title level="j" type="abbrev">Clin Kidney J</title>
						<idno type="ISSN">2048-8505</idno>
						<idno type="eISSN">2048-8513</idno>
						<imprint>
							<publisher>Oxford University Press (OUP)</publisher>
							<biblScope unit="volume">6</biblScope>
							<biblScope unit="issue">4</biblScope>
							<biblScope unit="page" from="395" to="401"/>
							<date type="published" when="2012-11-02">2 November 2012</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.1093/ckj/sfs131</idno>
					<idno type="PMID">27293567</idno>
					<idno type="PMCID">PMC4898329</idno>
					<ptr type="open-access" target="https://academic.oup.com/ckj/article-pdf/6/4/395/975162/sfs131.pdf" />
					<note type="submission">Received for publication: 27.6.12; Accepted in revised form: 18.8.12</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T23:22+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>cardiovascular risk factors</term>
					<term>chronic kidney disease progression</term>
					<term>end-stage renal disease</term>
					<term>IgA nephropathy</term>
					<term>metabolic syndrome</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Background. The metabolic syndrome is associated with modest but independent and additive risk of new onset chronic kidney disease (CKD) in several studies. The purpose of our study was to determine whether metabolic syndrome and other cardiovascular risk factors (hyperuricaemia and smoking) are associated with the progression of IgA nephropathy (IgAN). Methods. Two hundred and twenty three IgAN patients (107 with and 116 without metabolic syndrome) were examined. The primary renal end point was doubling of serum creatinine; secondary end points were reaching eGFR of ≤ 60 ml/min/1,73m 2 or eGFR of ≤30 ml/min/1.73 m 2 , and end-stage renal disease, ESRD (the composite of serum creatinine ≥500 µmol/l, initiation of dialysis treatment or transplantation). The association of metabolic syndrome with renal end points was examined using the Kaplan-Meier method and Cox models. Results. Metabolic syndrome established at the diagnosis or during follow-up of IgAN patients was significantly associated with the primary renal end point (unadjusted hazard ratio of doubling of serum creatinine, 95% confidence interval: 1.96 (1.17-1.33, p = 0.011). The association remained significant after adjustment for confounders: 1.70 (1.02-3.83, p = 0.040). Results were similar for secondary end points except ESRD which was not associated with the presence of metabolic syndrome. Hyperuricaemia and smoking were independent risk factors of progression. Survival curves stratified on metabolic syndrome status showed significant differences for the end points (p = 0.017-0.001) except for ESRD. Conclusions. Early diagnosis and treatment of metabolic syndrome, hyperuricaemia and smoking may be an additional cost-effective strategy for preventing the progression of IgAN.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>The term metabolic syndrome is commonly used to describe the clustering of cardiovascular risk factors, namely central obesity, hypertension, impaired glucose metabolism and dyslipidaemia. Metabolic syndrome is found in over 25% of adults in the USA and in several other industrialized countries, and there appears to be an increasing prevalence in higher age groups <ref type="bibr" target="#b0">[1]</ref>. Individuals with metabolic syndrome are at increased risk for cardiovascular diseases as well as cardiovascular and all-cause mortality <ref type="bibr" target="#b1">[2]</ref>.</p><p>The recent interest of nephrologists in metabolic syndrome increased after the publication of Chen et al. <ref type="bibr" target="#b2">[3]</ref>, demonstrating in a cross-sectional study that metabolic syndrome was associated with a 2.26-fold higher risk (1.68-4.03) of chronic kidney disease (CKD) in a sample representative of the US population. Other cross-sectional studies have also demonstrated a link between metabolic syndrome and CKD (see later). In the only longitudinal study, Kurella et al. <ref type="bibr" target="#b3">[4]</ref> demonstrated a significantly increased risk of incident CKD in non-diabetic adults with metabolic syndrome. However, the effects of metabolic syndrome on the progression of CKD beyond the contribution of impaired glucose metabolism and hypertension are far from being established with certainty.</p><p>IgA nephropathy (IgAN) is the most common primary glomerulonephritis and is an important cause of endstage renal disease (ESRD) worldwide <ref type="bibr" target="#b4">[5]</ref>. Long-term observation in many countries has shown that IgAN causes ESRD in as many as 40% of patients within 20 years after diagnosis <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b6">7]</ref>. Clinical presentation is usually with haematuria and with variable degrees of proteinuria. Pathologically, IgAN is characterized by the glomerular deposition of polymeric IgA1 mainly in the mesangium accompanied by mesangial hypercellularity, mesangial matrix expansion, and varying degrees of glomerulosclerosis and interstitial fibrosis. Adverse prognostic indicators include the presence of heavy proteinuria and hypertension, a significant reduction in glomerular filtration rate (GFR) at the time of renal biopsy and the extent of glomerulosclerosis and tubulointerstitial fibrosis on renal pathology <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b7">8]</ref>. In addition to these known risk factors, other cardiovascular risk factors, such as hypertriglyceridaemia, hyperuricaemia, excessive body weight or cigarette smoking have also been associated with the progression of IgAN in recent studies <ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref>. However, there are no data about the prevalence of metabolic syndrome in IgAN patients, and there have not been any reports of an association between metabolic syndrome and the progression of IgAN.</p><p>The purpose of the present study was to determine whether there are differences in the progression of IgAN according to the presence of metabolic syndrome and other cardiovascular risk factors at the time of diagnosis and during the course of IgAN. We emphasized that the clustering of cardiovascular risk factors is associated with a more severe progression of IgAN.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study population</head><p>We examined 240 biopsy-proven IgAN patients with normal or mild to moderately decreased renal function (CKD Stage 1-3) at the time of the diagnosis of IgAN. All of the patients were diagnosed in the Nephrology Center, Medical Faculty, University of Pécs, Hungary and followed-up in 3-to 6-month intervals by the same two nephrologists, TK and JN. Seventeen patients were not included in the statistical analyses of this study because of insufficient clinical data at the time of the diagnosis of IgAN. Further exclusion criteria were: secondary IgAN cases, rapidly progressive crescentic patients, patients with nephrotic syndrome and immunosuppressive treatment. The analysed cohort included 223 patients.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Definition of metabolic syndrome</head><p>All IgAN patients were analysed to determine whether criteria for metabolic syndrome were met by using a modified NCEP ATP III (National Cholesterol Education Programme-Adult Treatment Panel III) definition of metabolic syndrome <ref type="bibr" target="#b11">[12]</ref>. Metabolic syndrome was defined as any three or more of the following criteria: (i) fasting plasma glucose level of 5.6 mmol/L or higher or impaired glucose tolerance; (ii) triglyceride level of 1.7 mmol/L or higher or lipid-lowering drug treatment; (iii) high-density lipoprotein (HDL) cholesterol level &lt;1.0 mmol/L for men and &lt;1.3 mmol/L for women or drug treatment; (iv) body mass index (BMI) ≥30 kg/m 2 ; (v) hypertension with blood pressure ≥130/85 mmHg or antihypertensive treatment.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study measurements</head><p>Demographic, anthropometric and laboratory data as well as information about lifestyle habits were collected on all participants at the time of diagnosis and at each follow-up visit. Blood was collected by venepuncture after an overnight fast of at least 10 h at all follow-up examinations. The Central Laboratory of Medical Faculty, University of Pécs measured all serum chemistry levels in fresh samples with commercially available reagents. The glomerular filtration rate (eGFR; mL/min/1.73 m 2 ) was estimated with the Chronic Kidney Disease Epidemiology Collaboration equation <ref type="bibr" target="#b12">[13]</ref>. BMI was calculated as weight in kilograms divided by the square of the height in metres.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Definition of progression of IgAN</head><p>The primary renal outcome was the doubling of serum creatinine, secondary renal outcomes were the decrease of eGFR to ≤60 mL/min/1.73 m 2 , or to ≤30 mL/min/1.73 m <ref type="bibr" target="#b1">2</ref> or reaching ESRD (defined as the composite of a serum creatinine ≥500 µmol/L or the initiation of dialysis treatment or transplantation).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p>Data analysis was performed using the SPSS software program version 13.0 (SPSS Inc., Chicago, IL, USA). Continuous variables with normal distribution were expressed as mean ± standard deviation and were compared by using Student's t-tests. Variables with non-normal distribution were compared by the Mann-Whitney U-test, and categorical variables were expressed as percentage and compared by the χ 2 test. The mean renal survival time until the selected end points was calculated using the Kaplan-Meier method. Differences between the calculated mean renal survival times were compared using the log-rank test. The effect of confounders was assessed by Cox regression analysis.</p><p>Confounders were determined a priori based on theoretical considerations and by examining baseline covariate associations with metabolic syndrome and with the renal end points <ref type="bibr" target="#b13">[14]</ref>. Multivariate models were constructed with sequential adjustments for age and gender as well as for age, gender, uric acid, eGFR, smoking and angiotensin-converting enzyme inhibitors/angiotensin II receptor blocker (ACEis/ARB). A value of P &lt; 0.05 was considered statistically significant.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Baseline clinical data</head><p>The mean age of the 223 participants included in the analytic cohort was 36.4 ± 13.0 years, 72% were male and 28% were female. Metabolic syndrome was already present in 17% of participants (38 patients) at the diagnosis of IgAN and was diagnosed de novo in a further 31% of participants (69 patients) during the follow-up period. Analysing all (n = 223) IgAN patients together at the end of the follow-up period, the prevalence of zero, one, two, three and four parameters of the metabolic syndrome was 15 (7%), 48 (22%), 53 (24%), 91 (41%) and 16 (7%), respectively ( <ref type="figure" target="#fig_1">Figure 2</ref>). Sixty-eight (31%) patients were obese and impaired carbohydrate metabolism [impaired glucose tolerance (IGT), impaired fasting glucose (IFG) or diabetes mellitus] was present in 77 (35%) patients, HDL cholesterol was low in 108 (48%) patients, hypertriglyceridaemia was present in 133 (60%) patients and elevated blood pressure or antihypertensive treatment was present in 195 (87%) patients at the end of the follow-up period. Analysing together hypertriglyceridaemia, lower HDL cholesterol and statin treatment, 151 (68%) patients were dyslipidaemic.</p><p>Baseline characteristics of IgAN patients with and without metabolic syndrome are summarized in <ref type="table" target="#tab_1">Table 1</ref>. There were no significant differences in the age, sex, follow-up time or number of smokers between the two groups. Patients with metabolic syndrome had higher uric acid levels in addition to the expected higher values for BMI, triglyceride, glucose and lower HDL cholesterol level that define metabolic syndrome. At the time of the diagnosis of IgAN, the eGFR of patients with metabolic syndrome was lower (73.6 ± 31.8 versus 82.2 ± 27.7 mL/min/1.73 m 2 in patients without metabolic syndrome, P &lt; 0.05). However, at the end of the follow-up period, the difference between the eGFR of the two groups was more substantial (46.8 ± 31.6 versus 67.4 ± 35.3 mL/min/1.73 m 2 , P &lt; 0.001). The systolic and diastolic blood pressures of patients with metabolic syndrome were significantly higher <ref type="table" target="#tab_1">(Table 1)</ref>, and significantly more patients were treated with ACEi/ARB in the metabolic syndrome group (P &lt; 0.001).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Association of metabolic syndrome with progression of IgAN</head><p>Survival curves stratified on metabolic syndrome status showed statistically significant differences in the time to reach three different end points for the renal outcome: the doubling of serum creatinine (P = 0.009, <ref type="figure" target="#fig_0">Figure 1A</ref>), eGFR ≤60 mL/min/1.73 m 2 (P = 0.001, <ref type="figure" target="#fig_0">Figure 1B</ref>) and eGFR ≤30 mL/min/1.73 m 2 (P = 0.017, <ref type="figure" target="#fig_0">Figure 1C)</ref>. The difference in time to reach the composite end point of ESRD (defined as the composite of a serum creatinine ≥500 µmol/L or the initiation of dialysis treatment or transplantation) was not significant (P = 0.2).</p><p>Metabolic syndrome was significantly associated with the progression of IgAN in unadjusted Cox models for three different renal end points eGFR ≤60 mL/min/1.73 m 2 , eGFR ≤30/mL/min/1.73 m 2 and the doubling of serum creatinine <ref type="table">(Table 2)</ref>. The association remained significant after adjustment for confounders ( <ref type="table">Table 2)</ref>. The association, however, was not significant for the end points of ESRD in neither unadjusted nor adjusted Cox models ( <ref type="table">Table 2)</ref>. At the analysis of the effect of single traits of metabolic syndrome: obesity (yes/no, Y/N), hypertension (Y/N), dyslipidaemia (Y/N), dysglycaemia (Y/N) and complete metabolic syndrome on the prognosis of IgAN hypertension and complete metabolic syndrome were the two strongest influencing parameters ( <ref type="table">Table 3)</ref>.</p><p>In Cox regression analysis, higher uric acid level was also an independent risk factor for three different renal end points:</p><p>(i) eGFR ≤60 mL/min/1.73 m 2 [hazard ratio (HR) associated with a 1 mmol/L higher serum uric acid level: 1.003; 95% confidence interval (95% CI) 1.001-1.005]. (ii) eGFR ≤30 mL/min/1.73 m 2 (HR 1.002; 95% CI 1.001-1.005) and (iii) ESRD (HR 1.004; 95% CI 1.001-1.006).</p><p>Smoking was significantly associated with ESRD (HR 2.024; 95% CI 1.046-3.920).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>Our study showed that metabolic syndrome established at the time of diagnosis or during the follow-up of IgAN was significantly associated with the primary renal end point and remained significant after adjustment for confounders. Results were similar for the secondary end points except for ESRD. Hyperuricaemia was also an independent risk factor for all secondary end points, and smoking was an independent risk factor for ESRD. Survival curves stratified on metabolic syndrome status showed significant differences for the association with the various end points except for ESRD.</p><p>The criteria for metabolic syndrome diagnosis were set-up originally to identify those individuals most likely to develop cardiovascular diseases <ref type="bibr" target="#b14">[15]</ref>. There is no doubt nowadays that the patients with metabolic syndrome are at significantly higher risk for CKD too, as summarized by a number of review articles and by the recent meta-analysis of Thomas et al. <ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref>. Most of the observational studies discussed in these papers found a significant association between metabolic syndrome and CKD. The odds ratios for CKD in the different studies were: 2.60 in the National Health And Nutrition Examination Survey III (NHANES III) database <ref type="bibr" target="#b2">[3]</ref>  <ref type="bibr" target="#b31">[31]</ref> in Chinese adults as well as 1.30 in non-diabetic Taiwanese adults <ref type="bibr" target="#b32">[32]</ref>. However, the majority of the studies were cross-sectional and, as such, unable to establish a cause-effect relationship between metabolic syndrome and the reduction in kidney function, and also unable to determine if metabolic syndrome is associated with longitudinal changes in kidney function. In this study, we detected a significant association between metabolic syndrome and the progressive loss of kidney function except in ESRD, suggesting a potential effect of metabolic syndrome on the early progression of IgAN. The lower eGFR level of patients with metabolic syndrome seen at the time of diagnosis of IgAN suggests a potential effect of metabolic syndrome on the incidence of the renal disease too. Our observation that metabolic syndrome did not associate with the progression of IgAN in the end-stage of IgAN is in agreement with the results of the study of Lee et al. <ref type="bibr" target="#b33">[33]</ref> on CKD patients participating in the CKD prevention programme regulated by the Public Health Bureau of Taiwan. Among the components of metabolic syndrome, diabetic and hypertensive injuries, the two major aetiologies of CKD worldwide, have been well studied and described. Concerning the association between IgAN and diabetes, Fliser et al. <ref type="bibr" target="#b34">[34]</ref> published that insulin resistance and hyperinsulinaemia are already present in patients with incipient renal disease, among others in IgAN patients. In our present study, we found impaired glucose regulation (IGT, IFG or diabetes mellitus) in 77 (35%) patients. It is known that IgAN can also be superimposed on diabetic nephropathy or can be the only renal abnormality of diabetic patients. The association between IgAN and diabetes may not be coincidental, because the intraglomerular hypertension and hyperfiltration as well as biochemical alterations in the glomeruli of diabetic patients may facilitate the deposition of IgA1 immune complexes or aggregates. Furthermore, the abnormalities of the IgA immune system are common in Type 2 diabetes <ref type="bibr" target="#b35">[35]</ref>.</p><p>Hypertension is common in CKD patients and, similar to the general population, it predicts cardiovascular morbidity and mortality. Hypertensive CKD patients with metabolic syndrome have an excess cardiovascular risk. The relationship between blood pressure and mortality is U-shaped; low mean and diastolic blood pressure predicts early mortality <ref type="bibr" target="#b36">[36]</ref>. As we already mentioned in the introduction, the progression in IgAN is more severe in the presence of hypertension and strict blood-pressure control portents renal protection in IgAN <ref type="bibr" target="#b37">[37]</ref>. In our study, among the parameters of metabolic syndrome, hypertension had the greatest influence on the prognosis of IgAN.</p><p>Obesity has been associated with an increased risk for the incidence of CKD and for ESRD in several epidemiological studies <ref type="bibr" target="#b38">[38]</ref><ref type="bibr" target="#b39">[39]</ref><ref type="bibr" target="#b40">[40]</ref><ref type="bibr" target="#b41">[41]</ref>. In the examined populations, obesity as indicated by the elevated BMI was associated with decreased renal function and ESRD independent of the presence of hypertension and diabetes. Weight loss has a protective effect against the progression of CKD <ref type="bibr" target="#b40">[40]</ref>. Higher BMI shows a seemingly paradoxical association with better survival in advanced CKD and in ESRD, which could be related to a better nutritional status in patients with elevated BMI <ref type="bibr" target="#b42">[42]</ref>.Concerning IgAN patients, obesity was a predictive factor not only for the development of hypertension, but also for chronic renal failure and obese patients have glomerular enlargement and ultrastructural modification of the glomerular basement membrane <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b43">43]</ref>.</p><p>Dyslipidaemia, in particular atherogenic dyslipidaemia (high triglyceride and low HDL cholesterol), has been recognized as an independent risk factor for the development and progression of CKD in observational studies and in meta-analyses <ref type="bibr" target="#b44">[44,</ref><ref type="bibr" target="#b45">45]</ref>. Furthermore, the progressive decline in renal function may engender inflammation and oxidative stress, which could in turn induce various metabolic alterations, such as insulin resistance and diabetes, elevation of arterial blood pressure and hypertriglyceridaemia, leading to potential vicious cycles. In the study of Syrjänen et al. <ref type="bibr" target="#b9">[10]</ref>, elevated triglyceride levels were associated with progressive IgAN.</p><p>Recent epidemiologic and experimental evidence suggests a role for hyperuricaemia not only as a marker of reduced kidney function but also as a causal risk factor for the development and progression of renal disease <ref type="bibr" target="#b47">[46,</ref><ref type="bibr" target="#b48">47]</ref>. Serum uric acid was a GFR-independent longterm predictor of acute and chronic renal insufficiency in the Jerusalem Lipid Research Clinic cohort study <ref type="bibr" target="#b49">[48]</ref>.  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>398</head><p>T. Kovács et al.</p><p>There is a close connection between hypertension and hyperuricaemia and at the re-evaluation of metabolic syndrome; Reaven <ref type="bibr" target="#b14">[15]</ref> suggested to include hyperuricaemia among the criteria of metabolic syndrome. In the only previous study on IgAN patients, hyperuricaemia was found to be a predictor of poor prognosis similarly to our investigation <ref type="bibr" target="#b9">[10]</ref>. An association between smoking and CKD has been found in various studies, including in lupus patients, polycystic kidney disease, primary glomerular diseases and diabetic nephropathy <ref type="bibr" target="#b50">[49]</ref><ref type="bibr" target="#b51">[50]</ref><ref type="bibr" target="#b52">[51]</ref><ref type="bibr" target="#b53">[52]</ref>. In the present study, smoking was significantly associated with the progression to ESRD, similar to the study by Yamamoto et al. <ref type="bibr" target="#b10">[11]</ref> who, however, examined the smoking status only at time of diagnosis of IgAN.</p><p>Our study is notable for the well-characterized nature of the study population and the long follow-up of the patients by the same two nephrologists. Our study also has a number of limitations that have to be considered when interpreting the findings. This was a single-centre study hence the external validity of our findings may be limited. We lacked measurements of waist circumference as a better measure of abdominal obesity. Instead, we used BMI which is an acceptable alternative used in the World Health Organization classification of metabolic syndrome. This modification of the NCEP ATP III classification of metabolic syndrome we used was also used by Lea et al. examining the metabolic syndrome and the risk of progressive CKD in hypertensive African Americans <ref type="bibr" target="#b27">[27]</ref>. Our study did not involve and discuss proteinuria as a predictor of the progression of CKD, because proteinuria could be a clinical characteristic of IgAN and also a consequence of metabolic syndrome. This is the first study describing the frequent prevalence of metabolic syndrome at the time of diagnosis and during the follow-up of IgAN patients, and supporting the role of metabolic syndrome in the progression of IgAN. Hyperuricaemia and smoking seem to also be important risk factors of progression in IgAN. In conclusion, the early diagnosis and treatment of metabolic syndrome and hyperuricaemia, and cessation of smoking could be an added beneficial cost-effective strategy in the prevention of the progression of IgAN and in the prevention of the development of cardiovascular diseases, on the basis of the close connection between the progression of CKD and cardiovascular diseases. </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc>Time to reach the different end points (Kaplan-Meier analysis). (A) Time to doubling of serum creatinine (months). (B) Time to reach eGFR ≤60 mL/min/1.73 m 2 (months). (C) Time to reach eGFR ≤30 mL/min/1.73 m 2 (months).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 .</head><label>2</label><figDesc>Frequency of metabolic syndrome components at the end of follow-up.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 .</head><label>1</label><figDesc>Baseline characteristics of patients with and without metabolic syndrome</figDesc><table><row><cell></cell><cell>Metabolic</cell><cell>No metabolic</cell><cell></cell></row><row><cell></cell><cell>syndrome</cell><cell>syndrome</cell><cell></cell></row><row><cell></cell><cell>(n = 107)</cell><cell>(n = 116)</cell><cell>P-value</cell></row><row><cell>Age</cell><cell>37.9 ± 13.8</cell><cell>34.9 ± 12.2</cell><cell>0.089</cell></row><row><cell>Follow-up (months)</cell><cell>146.6 ± 112.5</cell><cell>146.1 ± 99.4</cell><cell>0.589</cell></row><row><cell>Sex (M/F)</cell><cell>81 (76%)/26</cell><cell>80 (69%)/36</cell><cell>0.296</cell></row><row><cell></cell><cell>(24%)</cell><cell>(31%)</cell><cell></cell></row><row><cell cols="2">Parameters of metabolic syndrome BMI (kg/m 2 ) 30.8 ± 4.8</cell><cell>24.9 ± 3.4</cell><cell>&lt;0.001</cell></row><row><cell>Systolic BP (Hgmm)</cell><cell>143 ± 20</cell><cell>136 ± 19</cell><cell>0.005</cell></row><row><cell cols="2">Diastolic BP (Hgmm) 89 ± 12</cell><cell>85 ± 12</cell><cell>0.014</cell></row><row><cell>Hypertension (Y/N)</cell><cell>105 (98%)/2</cell><cell>90 (78%)/26</cell><cell>&lt;0.001</cell></row><row><cell></cell><cell>(2%)</cell><cell>(22%)</cell><cell></cell></row><row><cell>Triglyceride</cell><cell>2.18 ± 1.21</cell><cell>1.59 ± 1.55</cell><cell>&lt;0.001</cell></row><row><cell>(mmol/L)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>HDL (mmol/L)</cell><cell>1.21 ± 0.48</cell><cell>1.39 ± 0.39</cell><cell>&lt;0.001</cell></row><row><cell>Blood sugar</cell><cell>6.32 ± 1.44</cell><cell>5.10 ± 0.81</cell><cell>&lt;0.001</cell></row><row><cell>(mmol/L)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Uric acid (mmol/L)</cell><cell>390 ± 124</cell><cell>351 ± 118</cell><cell>0.006</cell></row><row><cell>Smoking (Y/N)</cell><cell>27 (25%)/79</cell><cell>30 (26%)/83</cell><cell>0.879</cell></row><row><cell></cell><cell>(75%)</cell><cell>(74%)</cell><cell></cell></row><row><cell>Renal function</cell><cell></cell><cell></cell><cell></cell></row><row><cell>eGFR at the</cell><cell>73.6 ± 31.8</cell><cell>82.2 ± 27.7</cell><cell>&lt;0.05</cell></row><row><cell>diagnosis (mL/min/1.73 m 2 )</cell><cell></cell><cell></cell><cell></cell></row><row><cell>eGFR at the end of</cell><cell>46.8 ± 31.6</cell><cell>67.4 ± 35.3</cell><cell>&lt;0.001</cell></row><row><cell>follow-up (mL/min/ 1.73 m 2 )</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Drugs</cell><cell></cell><cell></cell><cell></cell></row><row><cell>ACEi/ARB (Y/N)</cell><cell>92 (86%)/15</cell><cell>73 (63%)/43</cell><cell>&lt;0.001</cell></row><row><cell></cell><cell>(14%)</cell><cell>(37%)</cell><cell></cell></row><row><cell>Statins (Y/N)</cell><cell>48 (45%)/59</cell><cell>19 (16%)/97</cell><cell>&lt;0.001</cell></row><row><cell></cell><cell>(55%)</cell><cell>(84%)</cell><cell></cell></row><row><cell cols="4">Data expressed as mean ± standard deviations and number of participants</cell></row><row><cell cols="2">(for categorical variables).</cell><cell></cell><cell></cell></row></table><note>BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; eGFR, estimated glomerular filtration rate; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker. Comparisons were made by t-tests or χ 2 tests.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .Table 2 .</head><label>32</label><figDesc>Crude hazard ratios (95% CI) of various end points associated with the presence of single metabolic syndrome components and metabolic syndrome itself Crude and adjusted hazard ratios (95% CIs) of various renal end points associated with the presence of metabolic syndrome Doubling of serum creatinine GFR Composite of ESRD ≤60 mL/min/1.73 m 2 ≤30 mL/min/1.73 m 2 Unadjusted 1.95 (1.16-3.28) 2.04 (1.30-3.10) 1.90 (1.11-3.24) 1.46 (0.80-2.66) P = 0.011 P = 0.002 P = 0.019 P = 0.207 Adjusted for age, gender 1.85 (1.10-3.11) 2.15 (1.37-3.37) 1.84 (1.07-3.14) 1.41 (0.78-2.57)</figDesc><table><row><cell cols="3">Metabolic syndrome and progression of IgA nephropathy</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>P = 0.019</cell><cell></cell><cell>P = 0.001</cell><cell>P = 0.025</cell><cell>P = 0.251</cell></row><row><cell cols="2">Adjusted for age, gender, uric acid, eGFR, smoking</cell><cell cols="2">1.81 (1.07-3.08)</cell><cell>2.04 (1.28-3.26)</cell><cell>1.81 (1.05-3.13)</cell><cell>1.36 (0.74-2.50)</cell></row><row><cell></cell><cell></cell><cell>P = 0.027</cell><cell></cell><cell>P = 0.003</cell><cell>P = 0.033</cell><cell>P = 0.320</cell></row><row><cell cols="4">Adjusted for age, gender, uric acid, eGFR, smoking, ACEi/ARB 1.70 (1.02-2.83)</cell><cell>2.11 (1.31-3.40)</cell><cell>1.64 (0.94-2.87)</cell><cell>1.29 (0.69-2.41)</cell></row><row><cell></cell><cell></cell><cell>P = 0.040</cell><cell></cell><cell>P = 0.002</cell><cell>P = 0.081</cell><cell>P = 0.419</cell></row><row><cell></cell><cell></cell><cell></cell><cell>GFR</cell><cell></cell></row><row><cell></cell><cell cols="2">Doubling of serum creatinine</cell><cell cols="2">≤60 mL/min/1.73 m 2</cell><cell>≤30 mL/min/1.73 m 2</cell><cell>Composite of ESRD</cell></row><row><cell>Obesity (Y/N)</cell><cell>0.95 (0.54-1.66)</cell><cell></cell><cell cols="2">1.52 (1.05-2.20)</cell><cell>1.29 (0.77-2.15)</cell><cell>1.25 (0.67-2.32)</cell></row><row><cell></cell><cell>P = 0.852</cell><cell></cell><cell>P = 0.026</cell><cell></cell><cell>P = 0.334</cell><cell>P = 0.484</cell></row><row><cell>Hypertension (Y/N)</cell><cell>5.73 (1.40-23.46)</cell><cell></cell><cell cols="2">4.50 (1.83-11.02)</cell><cell>5.93 (1.45-24,24)</cell><cell>3.89 (0.94-16.07)</cell></row><row><cell></cell><cell>P = 0.015</cell><cell></cell><cell>P = 0.001</cell><cell></cell><cell>P = 0.013</cell><cell>P = 0.061</cell></row><row><cell>Dyslipidaemia (Y/N)</cell><cell>1.65 (0.94-2.92)</cell><cell></cell><cell cols="2">1.44 (0.97-2.14)</cell><cell>1.64 (0.95-2.85)</cell><cell>1.32 (0.69-2.53)</cell></row><row><cell></cell><cell>P = 0.082</cell><cell></cell><cell>P = 0.073</cell><cell></cell><cell>P = 0.077</cell><cell>P = 0.395</cell></row><row><cell>Dysglicaemia (Y/N)</cell><cell>0.67 (0.41-1.10)</cell><cell></cell><cell cols="2">0.60 (0.42-0.86)</cell><cell>0.67 (0.42-1.09)</cell><cell>0.88 (0.49-1.60)</cell></row><row><cell></cell><cell>P = 0.116</cell><cell></cell><cell>P = 0.005</cell><cell></cell><cell>P = 0.110</cell><cell>P = 0.680</cell></row><row><cell>Metabolic syndrome (Y/N)</cell><cell>1.87 (1.12-3.12)</cell><cell></cell><cell cols="2">2.04 (1.42-2.93)</cell><cell>1.98 (1.20-3.25)</cell><cell>1.470 (0.81-2.66)</cell></row><row><cell></cell><cell>P = 0.016</cell><cell></cell><cell>P &lt; 0.001</cell><cell></cell><cell>P = 0.007</cell><cell>P = 0.207</cell></row></table><note></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="396">T.Kovács et al.   </note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0" />
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)</title>
	</analytic>
	<monogr>
		<title level="j">Expert Panel on Detection</title>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="page" from="2486" to="2497" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
	<note>JAMA</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hanna-Maaria</forename><forename type="middle">M</forename><surname>Lakka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">E</forename><surname>Laaksonen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">A</forename><surname>Lakka</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.288.21.2709</idno>
		<idno type="PMID">12460094</idno>
		<ptr type="open-access" target="https://jamanetwork.com/journals/jama/articlepdf/1108360/JOC21220.pdf" />
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<title level="j" type="abbrev">JAMA</title>
		<idno type="ISSN">0098-7484</idno>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="issue">21</biblScope>
			<biblScope unit="page">2709</biblScope>
			<date type="published" when="2002-12-04" />
			<publisher>American Medical Association (AMA)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">METABOLIC SYNDROME AND RISK OF CHRONIC KIDNEY DISEASE IN US ADULTS</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Muntner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">L</forename><surname>Hamm</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Batuman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Fonseca</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Whelton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>He</surname></persName>
		</author>
		<idno type="DOI">10.1097/00004872-200402001-00207</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Hypertension</title>
		<title level="j" type="abbrev">Journal of Hypertension</title>
		<idno type="ISSN">0263-6352</idno>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">Suppl. 1</biblScope>
			<biblScope unit="page">S50</biblScope>
			<date type="published" when="2004-02" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Metabolic Syndrome and the Risk for Chronic Kidney Disease among Nondiabetic Adults</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Kurella</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Lo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">M</forename><surname>Chertow</surname></persName>
		</author>
		<idno type="DOI">10.1681/asn.2005010106</idno>
		<idno type="PMID">15901764</idno>
		<ptr type="open-access" target="https://jasn.asnjournals.org/content/16/7/2134.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of the American Society of Nephrology</title>
		<title level="j" type="abbrev">Journal of the American Society of Nephrology</title>
		<idno type="ISSN">1046-6673</idno>
		<idno type="ISSNe">1533-3450</idno>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="2134" to="2140" />
			<date type="published" when="2005-04-20" />
			<publisher>American Society of Nephrology (ASN)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Epidemiology and Ancestral Difference</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Francesco</forename><forename type="middle">P</forename><surname>Schena</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Francesco</forename><surname>Pesce</surname></persName>
		</author>
		<idno type="DOI">10.1142/9789812835871_0002</idno>
	</analytic>
	<monogr>
		<title level="m">Recent Advances in Iga Nephropathy</title>
		<editor>: Lai KN</editor>
		<meeting><address><addrLine>New Jersey</addrLine></address></meeting>
		<imprint>
			<publisher>WORLD SCIENTIFIC</publisher>
			<date type="published" when="2009-01" />
			<biblScope unit="page" from="9" to="19" />
		</imprint>
	</monogr>
	<note>Recent Advances in IgA Nephropathy</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Clinical Course of Primary IgA Nephropathy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">François</forename><forename type="middle">C</forename><surname>Berthoux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hesham</forename><surname>Mohey</surname></persName>
		</author>
		<idno type="DOI">10.1142/9789812835871_0008</idno>
	</analytic>
	<monogr>
		<title level="m">Recent Advances in Iga Nephropathy</title>
		<editor>: Lai KN</editor>
		<meeting><address><addrLine>New Jersey</addrLine></address></meeting>
		<imprint>
			<publisher>WORLD SCIENTIFIC</publisher>
			<date type="published" when="2009-01" />
			<biblScope unit="page" from="107" to="119" />
		</imprint>
	</monogr>
	<note>Recent Advances in IgA Nephropathy</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">IgA nephropathy: recent developments</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Floege</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Feehally</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="2395" to="2403" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Barrat</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Feehally</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Iga</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="2088" to="2097" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fabrice</forename><surname>Bonnet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carole</forename><surname>Deprele</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Agnes</forename><surname>Sassolas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Philippe</forename><surname>Moulin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eric</forename><surname>Alamartine</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">François</forename><surname>Berthezène</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">François</forename><surname>Berthoux</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0272-6386(01)80120-7</idno>
		<idno type="PMID">11273871</idno>
		<idno type="PII">S0272-6386(01)80120-7</idno>
		<idno type="ark">ark:/67375/6H6-QDRB2VHD-Z</idno>
		<idno type="istexId">F3C46648C73C890995A1818F649A44F0BE431A37</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Kidney Diseases</title>
		<title level="j" type="abbrev">American Journal of Kidney Diseases</title>
		<idno type="ISSN">0272-6386</idno>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="720" to="727" />
			<date type="published" when="2001-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jaana</forename><surname>Syrjänen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jukka</forename><surname>Mustonen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Amos</forename><surname>Pasternack</surname></persName>
		</author>
		<idno type="DOI">10.1093/ndt/15.1.34</idno>
		<idno type="PMID">10607765</idno>
		<idno type="PII">1460-2385</idno>
		<idno type="ark">ark:/67375/HXZ-BN0HR9GL-F</idno>
		<idno type="istexId">B59175996260C205F8A52298727B74708878CB34</idno>
		<ptr type="open-access" target="https://academic.oup.com/ndt/article-pdf/15/1/34/23769274/0150034.pdf" />
	</analytic>
	<monogr>
		<title level="j">Nephrology Dialysis Transplantation</title>
		<idno type="ISSN">0931-0509</idno>
		<idno type="ISSNe">1460-2385</idno>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="34" to="42" />
			<date type="published" when="2000-01-01" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Cigarette Smoking and Progression of IgA Nephropathy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ryohei</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasuyuki</forename><surname>Nagasawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tatsuya</forename><surname>Shoji</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hirotsugu</forename><surname>Iwatani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takayuki</forename><surname>Hamano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Noritaka</forename><surname>Kawada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazunori</forename><surname>Inoue</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takuya</forename><surname>Uehata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tetsuya</forename><surname>Kaneko</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Noriyuki</forename><surname>Okada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Toshiki</forename><surname>Moriyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masaru</forename><surname>Horio</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Atsushi</forename><surname>Yamauchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshiharu</forename><surname>Tsubakihara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Enyu</forename><surname>Imai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiromi</forename><surname>Rakugi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshitaka</forename><surname>Isaka</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.ajkd.2010.02.351</idno>
		<idno type="PMID">20471735</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Kidney Diseases</title>
		<title level="j" type="abbrev">American Journal of Kidney Diseases</title>
		<idno type="ISSN">0272-6386</idno>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="313" to="324" />
			<date type="published" when="2010-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">M</forename><surname>Grundy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">I</forename><surname>Cleeman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">R</forename><surname>Daniels</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.105.169404</idno>
		<idno type="PMID">16157765</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.105.169404" />
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<title level="j" type="abbrev">Circulation</title>
		<idno type="ISSN">0009-7322</idno>
		<idno type="ISSNe">1524-4539</idno>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="2735" to="2752" />
			<date type="published" when="2005-10-25" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">A New Equation to Estimate Glomerular Filtration Rate</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">S</forename><surname>Levey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lesley</forename><forename type="middle">A</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christopher</forename><forename type="middle">H</forename><surname>Schmid</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yaping</forename><forename type="middle">(lucy)</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alejandro</forename><forename type="middle">F</forename><surname>Castro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Harold</forename><forename type="middle">I</forename><surname>Feldman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">W</forename><surname>Kusek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><surname>Eggers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frederick</forename><surname>Van Lente</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tom</forename><surname>Greene</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Josef</forename><surname>Coresh</surname></persName>
		</author>
		<idno type="DOI">10.7326/0003-4819-150-9-200905050-00006</idno>
		<idno type="PMID">19414839</idno>
		<idno type="PMCID">PMC2763564</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2763564?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Annals of Internal Medicine</title>
		<title level="j" type="abbrev">Ann Intern Med</title>
		<idno type="ISSN">0003-4819</idno>
		<imprint>
			<biblScope unit="volume">150</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">604</biblScope>
			<date type="published" when="2009-05-05" />
			<publisher>American College of Physicians</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Cohort Studies: Marching Forward</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Thadhani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Tonelli</surname></persName>
		</author>
		<idno type="DOI">10.2215/cjn.00080106</idno>
		<idno type="PMID">17699334</idno>
		<ptr type="open-access" target="https://cjasn.asnjournals.org/content/1/5/1117.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Clinical Journal of the American Society of Nephrology</title>
		<title level="j" type="abbrev">Clinical Journal of the American Society of Nephrology</title>
		<idno type="ISSN">1555-9041</idno>
		<idno type="ISSNe">1555-905X</idno>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1117" to="1123" />
			<date type="published" when="2006-07-12" />
			<publisher>American Society of Nephrology (ASN)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Metabolic Syndrome: Pathophysiology and Implications for Management of Cardiovascular Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Reaven</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.cir.0000019884.36724.d9</idno>
		<idno type="PMID">12119239</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.0000019884.36724.D9" />
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<idno type="ISSN">0009-7322</idno>
		<idno type="ISSNe">1524-4539</idno>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="286" to="288" />
			<date type="published" when="2002-07-16" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Cardiometabolic syndrome and chronic kidney disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guido</forename><surname>Lastra</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Camila</forename><surname>Manrique</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Samy</forename><forename type="middle">I</forename><surname>Mcfarlane</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">James</forename><forename type="middle">R</forename><surname>Sowers</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11892-006-0036-5</idno>
		<idno type="PMID">16898573</idno>
	</analytic>
	<monogr>
		<title level="j">Current Diabetes Reports</title>
		<title level="j" type="abbrev">Curr Diab Rep</title>
		<idno type="ISSN">1534-4827</idno>
		<idno type="ISSNe">1539-0829</idno>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="207" to="212" />
			<date type="published" when="2006-05" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Metabolic syndrome: at the crossroads of cardiorenal risk</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Natali</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Pucci</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Boldrini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nephrol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="29" to="38" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Role of Obesity and Metabolic Alterations in Hypertensive Renal Disease and in Chronic Kidney Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carmine</forename><surname>Zoccali</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniela</forename><surname>Leonardis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Francesca</forename><surname>Mallamaci</surname></persName>
		</author>
		<idno type="DOI">10.1002/9781444318456.ch43</idno>
	</analytic>
	<monogr>
		<title level="m">Nutritional and Metabolic Bases of Cardiovascular Disease</title>
		<imprint>
			<publisher>Wiley-Blackwell</publisher>
			<date type="published" when="2011-01-12" />
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="345" to="352" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Renal Manifestations in the Metabolic Syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Locatelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Pozzoni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Del</forename><surname>Vecchio</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename></persName>
		</author>
		<idno type="DOI">10.1681/asn.2005121332</idno>
		<idno type="PMID">16565254</idno>
		<ptr type="open-access" target="https://jasn.asnjournals.org/content/jnephrol/17/4_suppl_2/S81.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of the American Society of Nephrology</title>
		<title level="j" type="abbrev">Journal of the American Society of Nephrology</title>
		<idno type="ISSN">1046-6673</idno>
		<idno type="ISSNe">1533-3450</idno>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">4_suppl_2</biblScope>
			<biblScope unit="page" from="S81" to="S85" />
			<date type="published" when="2006-04-01" />
			<publisher>American Society of Nephrology (ASN)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Metabolic Syndrome and Kidney Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eberhard</forename><surname>Ritz</surname></persName>
		</author>
		<idno type="DOI">10.1159/000110566</idno>
		<idno type="PMID">18182798</idno>
	</analytic>
	<monogr>
		<title level="j">Blood Purification</title>
		<title level="j" type="abbrev">Blood Purif</title>
		<idno type="ISSN">0253-5068</idno>
		<idno type="ISSNe">1421-9735</idno>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="59" to="62" />
			<date type="published" when="2008" />
			<publisher>S. Karger AG</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The metabolic syndrome and chronic kidney disease epidemics: severing the link</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Mallamaci</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Leonardis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Tripepi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Port J Nephrol Hypert</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="71" to="76" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Metabolic Syndrome and Kidney Disease: A Systematic Review and Meta-analysis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">R</forename><surname>Sehgal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">R</forename><surname>Kashyap</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">R</forename><surname>Srinivas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Kirwan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">D</forename><surname>Navaneethan</surname></persName>
		</author>
		<idno type="DOI">10.2215/cjn.02180311</idno>
		<idno type="PMID">21852664</idno>
		<idno type="PMCID">PMC3186450</idno>
		<ptr type="open-access" target="https://cjasn.asnjournals.org/content/6/10/2364.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Clinical Journal of the American Society of Nephrology</title>
		<title level="j" type="abbrev">Clinical Journal of the American Society of Nephrology</title>
		<idno type="ISSN">1555-9041</idno>
		<idno type="ISSNe">1555-905X</idno>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2364" to="2373" />
			<date type="published" when="2011-08-18" />
			<publisher>American Society of Nephrology (ASN)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Clin J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="2364" to="2373" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Metabolic Syndrome and the Development of CKD in American Indians: The Strong Heart Study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jaime</forename><surname>Lucove</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Suma</forename><surname>Vupputuri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerardo</forename><surname>Heiss</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kari</forename><surname>North</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marie</forename><surname>Russell</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.ajkd.2007.09.014</idno>
		<idno type="PMID">18155529</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Kidney Diseases</title>
		<title level="j" type="abbrev">American Journal of Kidney Diseases</title>
		<idno type="ISSN">0272-6386</idno>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="21" to="28" />
			<date type="published" when="2008-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Metabolic syndrome and chronic kidney disease in Okinawa, Japan</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Shiohira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Uezu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Higa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Iseki</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.ki.5000050</idno>
		<idno type="PMID">16408128</idno>
	</analytic>
	<monogr>
		<title level="j">Kidney International</title>
		<title level="j" type="abbrev">Kidney International</title>
		<idno type="ISSN">0085-2538</idno>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="369" to="374" />
			<date type="published" when="2006-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Are Patients Who Have Metabolic Syndrome without Diabetes at Risk for Developing Chronic Kidney Disease? Evidence Based on Data from a Large Cohort Screening Population</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Rashidi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Ghanbarian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Azizi</surname></persName>
		</author>
		<idno type="DOI">10.2215/cjn.01020207</idno>
		<idno type="PMID">17702729</idno>
		<ptr type="open-access" target="https://cjasn.asnjournals.org/content/2/5/976.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Clinical Journal of the American Society of Nephrology</title>
		<title level="j" type="abbrev">Clinical Journal of the American Society of Nephrology</title>
		<idno type="ISSN">1555-9041</idno>
		<idno type="ISSNe">1555-905X</idno>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="976" to="983" />
			<date type="published" when="2007-08-16" />
			<publisher>American Society of Nephrology (ASN)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Association between the metabolic syndrome and chronic kidney disease in Chinese adults</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C-S</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">L</forename><surname>Hamm</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Muntner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Batuman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C-H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">K</forename><surname>Whelton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>He</surname></persName>
		</author>
		<idno type="DOI">10.1093/ndt/gfl759</idno>
		<idno type="PMID">17272313</idno>
		<idno type="ark">ark:/67375/HXZ-72ZVNT52-P</idno>
		<idno type="istexId">C757CC7C09562274536F4E05DFB9DAB450E586AE</idno>
		<ptr type="open-access" target="https://academic.oup.com/ndt/article-pdf/22/4/1100/7987830/gfl759.pdf" />
	</analytic>
	<monogr>
		<title level="j">Nephrology Dialysis Transplantation</title>
		<title level="j" type="abbrev">Nephrology Dialysis Transplantation</title>
		<idno type="ISSN">0931-0509</idno>
		<idno type="ISSNe">1460-2385</idno>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1100" to="1106" />
			<date type="published" when="2007-01-25" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Metabolic Syndrome, Proteinuria, and the Risk of Progressive CKD in Hypertensive African Americans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Janice</forename><surname>Lea</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Deanna</forename><surname>Cheek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Denise</forename><surname>Thornley-Brown</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lawrence</forename><surname>Appel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lawrence</forename><surname>Agodoa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gabriel</forename><surname>Contreras</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jennifer</forename><surname>Gassman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jim</forename><surname>Lash</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Edgar</forename><forename type="middle">R</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Otelio</forename><surname>Randall</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xuelei</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><surname>Mcclellan</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.ajkd.2008.01.013</idno>
		<idno type="PMID">18436083</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Kidney Diseases</title>
		<title level="j" type="abbrev">American Journal of Kidney Diseases</title>
		<idno type="ISSN">0272-6386</idno>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="732" to="740" />
			<date type="published" when="2008-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Metabolic Syndrome Predicts New Onset of Chronic Kidney Disease in 5,829 Patients With Type 2 Diabetes: A 5-year prospective analysis of the Hong Kong Diabetes Registry</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">O Y</forename><surname>Luk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W-Y</forename><surname>So</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">C W</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">P S</forename><surname>Kong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Ozaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">S W</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">W L</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">W Y</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">C C</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C N</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C Y</forename><surname>Tong</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc08-0971</idno>
		<idno type="PMID">18835954</idno>
		<idno type="PMCID">PMC2584195</idno>
		<ptr type="open-access" target="http://care.diabetesjournals.org/content/31/12/2357.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<title level="j" type="abbrev">Diabetes Care</title>
		<idno type="ISSN">0149-5992</idno>
		<idno type="ISSNe">1935-5548</idno>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2357" to="2361" />
			<date type="published" when="2008-10-03" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Chronic kidney disease and metabolic syndrome in a general Korean population: the Third Korea National Health and Nutrition Examination Survey (KNHANES III) Study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">Y</forename><surname>Jang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I-H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">Y</forename><surname>Ju</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Ahn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D-K</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">W</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.1093/pubmed/fdp127</idno>
		<idno type="PMID">20061374</idno>
		<idno type="ark">ark:/67375/HXZ-QPC5ZQQF-D</idno>
		<idno type="istexId">FDB40C55EB1F81210A8055370688EBF79E2D79BA</idno>
		<ptr type="open-access" target="https://academic.oup.com/jpubhealth/article-pdf/32/4/538/4353306/fdp127.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Public Health</title>
		<title level="j" type="abbrev">Journal of Public Health</title>
		<idno type="ISSN">1741-3842</idno>
		<idno type="ISSNe">1741-3850</idno>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="538" to="546" />
			<date type="published" when="2010-01-08" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Metabolic Syndrome and Chronic Kidney Disease in a Chinese Population Aged 40 Years and Older</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luxia</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Li</forename><surname>Zuo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fang</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mei</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shuyu</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lisheng</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Haiyan</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.4065/82.7.822</idno>
		<idno type="PMID">17605962</idno>
	</analytic>
	<monogr>
		<title level="j">Mayo Clinic Proceedings</title>
		<title level="j" type="abbrev">Mayo Clinic Proceedings</title>
		<idno type="ISSN">0025-6196</idno>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="822" to="827" />
			<date type="published" when="2007-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Impact of metabolic syndrome on the incidence of chronic kidney disease: A Chinese cohort study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tsan</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chi-Hong</forename><surname>Chu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chih-Hsung</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Po-Chien</forename><surname>Hsieh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tieh-Chi</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chyi-Huey</forename><surname>Bai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">San-Lin</forename><surname>You</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lee-Ching</forename><surname>Hwang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chih-Ming</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chien-An</forename><surname>Sun</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1440-1797.2012.01607.x</idno>
		<idno type="PMID">22487238</idno>
		<idno type="ark">ark:/67375/WNG-R6VPM90N-G</idno>
		<idno type="istexId">D5C676025A9AA39AA0F1A80787A3188441B26437</idno>
	</analytic>
	<monogr>
		<title level="j">Nephrology</title>
		<idno type="ISSN">1320-5358</idno>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="532" to="538" />
			<date type="published" when="2012-07-23" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Metabolic syndrome and the development of chronic kidney disease among 118 924 non-diabetic Taiwanese in a retrospective cohort</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Feng</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Qiushan</forename><surname>Tao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Siyan</forename><surname>Zhan</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1440-1797.2009.01150.x</idno>
		<idno type="PMID">20377775</idno>
		<idno type="ark">ark:/67375/WNG-MFR43KQF-R</idno>
		<idno type="istexId">0413B506324A66E0D342596861D1C722A7CE9CAD</idno>
	</analytic>
	<monogr>
		<title level="j">Nephrology</title>
		<idno type="ISSN">1320-5358</idno>
		<idno type="ISSNe">1440-1797</idno>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="84" to="92" />
			<date type="published" when="2010-02" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Metabolic syndrome loses its predictive power in late-stage chronic kidney disease progression – a paradoxical phenomenon</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C-C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">Y</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I-W</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S-Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M-S</forename><surname>Wu</surname></persName>
		</author>
		<idno type="DOI">10.5414/cnp75141</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical Nephrology</title>
		<title level="j" type="abbrev">CN</title>
		<idno type="ISSN">0301-0430</idno>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="issue">02</biblScope>
			<biblScope unit="page" from="141" to="149" />
			<date type="published" when="2011-02-01" />
			<publisher>Dustri-Verlgag Dr. Karl Feistle</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Danilo</forename><surname>Fliser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanni</forename><surname>Pacini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Renate</forename><surname>Engelleiter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexandra</forename><surname>Kautzky-Willer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rudolf</forename><surname>Prager</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Edward</forename><surname>Franek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eberhard</forename><surname>Ritz</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1523-1755.1998.00898.x</idno>
		<idno type="PMID">9573550</idno>
	</analytic>
	<monogr>
		<title level="j">Kidney International</title>
		<title level="j" type="abbrev">Kidney International</title>
		<idno type="ISSN">0085-2538</idno>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1343" to="1347" />
			<date type="published" when="1998-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title level="m" type="main">Recent Advances in IgA Nephropathy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Nagy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Kovacs</surname></persName>
		</author>
		<editor>: Lai KN</editor>
		<imprint>
			<date type="published" when="2009" />
			<publisher>World Scientific Publishing Co</publisher>
			<biblScope unit="page" from="121" to="138" />
			<pubPlace>New Jersey</pubPlace>
		</imprint>
	</monogr>
	<note>Special clinical syndromes</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Csaba</forename><forename type="middle">P</forename><surname>Kovesdy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bhairvi</forename><forename type="middle">K</forename><surname>Trivedi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kamyar</forename><surname>Kalantar-Zadeh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">E</forename><surname>Anderson</surname></persName>
		</author>
		<idno type="DOI">10.1093/ndt/gfk057</idno>
		<idno type="PMID">16421161</idno>
		<idno type="ark">ark:/67375/HXZ-02RGBQ83-W</idno>
		<idno type="istexId">3D64E8E32110937F91A297DE9D68A90A04E24CA3</idno>
		<ptr type="open-access" target="https://academic.oup.com/ndt/article-pdf/21/5/1257/6901019/gfk057.pdf" />
	</analytic>
	<monogr>
		<title level="j">Nephrology Dialysis Transplantation</title>
		<idno type="ISSN">0931-0509</idno>
		<idno type="ISSNe">1460-2385</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1257" to="1262" />
			<date type="published" when="2006-01-18" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Renal protection in IgA nephropathy requires strict blood pressure control</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Judit</forename><surname>Nagy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tibor</forename><surname>Kovács</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">István</forename><surname>Wittmann</surname></persName>
		</author>
		<idno type="DOI">10.1093/ndt/gfh920</idno>
		<idno type="PMID">15956069</idno>
		<idno type="ark">ark:/67375/HXZ-KTLB67M8-N</idno>
		<idno type="istexId">0F2516E7EB70EB8006FF7AC4ED86E003BFBE875A</idno>
		<ptr type="open-access" target="https://academic.oup.com/ndt/article-pdf/20/8/1533/5419635/gfh920.pdf" />
	</analytic>
	<monogr>
		<title level="j">Nephrology Dialysis Transplantation</title>
		<idno type="ISSN">0931-0509</idno>
		<idno type="ISSNe">1460-2385</idno>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1533" to="1539" />
			<date type="published" when="2005-06-14" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Associations of Body Size with Metabolic Syndrome and Mortality in Moderate Chronic Kidney Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bch</forename><forename type="middle">C H</forename><surname>Kwan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Murtaugh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Beddhu</surname></persName>
		</author>
		<idno type="DOI">10.2215/cjn.04221206</idno>
		<idno type="PMID">17702712</idno>
		<ptr type="open-access" target="https://cjasn.asnjournals.org/content/2/5/992.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Clinical Journal of the American Society of Nephrology</title>
		<title level="j" type="abbrev">Clinical Journal of the American Society of Nephrology</title>
		<idno type="ISSN">1555-9041</idno>
		<idno type="ISSNe">1555-905X</idno>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="992" to="998" />
			<date type="published" when="2007-08-16" />
			<publisher>American Society of Nephrology (ASN)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">The Effect of Obesity on Chronic Kidney Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joel</forename><forename type="middle">D</forename><surname>Kopple</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Usama</forename><surname>Feroze</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.jrn.2010.10.009</idno>
		<idno type="PMID">21195923</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Renal Nutrition</title>
		<title level="j" type="abbrev">Journal of Renal Nutrition</title>
		<idno type="ISSN">1051-2276</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="66" to="71" />
			<date type="published" when="2011-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Body Mass Index and Risk for End-Stage Renal Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chi-Yuan</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carlos</forename><surname>Iribarren</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alan</forename><forename type="middle">S</forename><surname>Go</surname></persName>
		</author>
		<idno type="DOI">10.7326/0003-4819-144-9-200605020-00022</idno>
		<ptr type="open-access" target="http://annals.org/data/journals/aim/20114/0000605-200605020-00017.pdf" />
	</analytic>
	<monogr>
		<title level="j">Annals of Internal Medicine</title>
		<title level="j" type="abbrev">Ann Intern Med</title>
		<idno type="ISSN">0003-4819</idno>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">701</biblScope>
			<date type="published" when="2006-05-02" />
			<publisher>American College of Physicians</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Body Mass Index and Mortality in CKD</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Magdalena</forename><surname>Madero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">J</forename><surname>Sarnak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xuelei</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carmen</forename><forename type="middle">Castaneda</forename><surname>Sceppa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tom</forename><surname>Greene</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerald</forename><forename type="middle">J</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">W</forename><surname>Kusek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Allan</forename><forename type="middle">J</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">S</forename><surname>Levey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vandana</forename><surname>Menon</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.ajkd.2007.06.004</idno>
		<idno type="PMID">17720519</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Kidney Diseases</title>
		<title level="j" type="abbrev">American Journal of Kidney Diseases</title>
		<idno type="ISSN">0272-6386</idno>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="404" to="411" />
			<date type="published" when="2007-09" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Paradoxical Association Between Body Mass Index and Mortality in Men With CKD Not Yet on Dialysis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Csaba</forename><forename type="middle">P</forename><surname>Kovesdy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">E</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kamyar</forename><surname>Kalantar-Zadeh</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.ajkd.2007.02.277</idno>
		<idno type="PMID">17472839</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Kidney Diseases</title>
		<title level="j" type="abbrev">American Journal of Kidney Diseases</title>
		<idno type="ISSN">0272-6386</idno>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="581" to="591" />
			<date type="published" when="2007-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Impact of Obesity on IgA Nephropathy: Comparative Ultrastructural Study between Obese and Non-Obese Patients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mari</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sachiko</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yukako</forename><surname>Iwasaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeshi</forename><surname>Sugishita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Satomi</forename><surname>Yonemoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tatsuo</forename><surname>Tsukamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Satoshi</forename><surname>Fukui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kosho</forename><surname>Takasu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eri</forename><surname>Muso</surname></persName>
		</author>
		<idno type="DOI">10.1159/000213084</idno>
		<idno type="PMID">19390205</idno>
	</analytic>
	<monogr>
		<title level="j">Nephron Clinical Practice</title>
		<title level="j" type="abbrev">Nephron Clin Pract</title>
		<idno type="ISSN">1660-2110</idno>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="c71" to="c78" />
			<date type="published" when="2009" />
			<publisher>S. Karger AG</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities Study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><surname>Muntner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Josef</forename><surname>Coresh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">Clinton</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><surname>Eckfeldt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">J</forename><surname>Klag</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1523-1755.2000.00165.x</idno>
		<idno type="PMID">10886574</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/5498/89f1809add1c26adb32a9db6d5f6bb993d36.pdf" />
	</analytic>
	<monogr>
		<title level="j">Kidney International</title>
		<title level="j" type="abbrev">Kidney International</title>
		<idno type="ISSN">0085-2538</idno>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="293" to="301" />
			<date type="published" when="2000-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Effect of lipid reduction on the progression of renal disease: A meta-analysis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Linda</forename><forename type="middle">F</forename><surname>Fried</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Trevor</forename><forename type="middle">J</forename><surname>Orchard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bertram</forename><forename type="middle">L</forename><surname>Kasiske</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1523-1755.2001.00487.x</idno>
		<idno type="PMID">11135079</idno>
	</analytic>
	<monogr>
		<title level="j">Kidney International</title>
		<title level="j" type="abbrev">Kidney International</title>
		<idno type="ISSN">0085-2538</idno>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="260" to="269" />
			<date type="published" when="2001-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<monogr>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Kovács</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Uric acid: a novel mediator and marker of risk in chronic kidney disease?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">D</forename><surname>Feig</surname></persName>
		</author>
		<idno type="DOI">10.1097/mnh.0b013e328330d9d0</idno>
		<idno type="PMID">19654543</idno>
		<idno type="PMCID">PMC2885828</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2885828?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Current Opinion in Nephrology and Hypertension</title>
		<title level="j" type="abbrev">Current Opinion in Nephrology and Hypertension</title>
		<idno type="ISSN">1062-4821</idno>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="526" to="530" />
			<date type="published" when="2009-11" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Elevated Uric Acid Increases the Risk for Kidney Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">P</forename><surname>Obermayr</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Temml</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Gutjahr</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Knechtelsdorfer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Oberbauer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Klauser-Braun</surname></persName>
		</author>
		<idno type="DOI">10.1681/asn.2008010080</idno>
		<idno type="PMID">18799720</idno>
		<idno type="PMCID">PMC2588108</idno>
		<ptr type="open-access" target="https://jasn.asnjournals.org/content/19/12/2407.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of the American Society of Nephrology</title>
		<title level="j" type="abbrev">Journal of the American Society of Nephrology</title>
		<idno type="ISSN">1046-6673</idno>
		<idno type="ISSNe">1533-3450</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2407" to="2413" />
			<date type="published" when="2008-11-19" />
			<publisher>American Society of Nephrology (ASN)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Iddo</forename><forename type="middle">Z</forename><surname>Ben-Dov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeremy</forename><forename type="middle">D</forename><surname>Kark</surname></persName>
		</author>
		<idno type="DOI">10.1093/ndt/gfq740</idno>
		<idno type="PMID">21220750</idno>
		<idno type="PMCID">PMC3145913</idno>
		<ptr type="open-access" target="https://academic.oup.com/ndt/article-pdf/26/8/2558/17108180/gfq740.pdf" />
	</analytic>
	<monogr>
		<title level="j">Nephrology Dialysis Transplantation</title>
		<idno type="ISSN">0931-0509</idno>
		<idno type="ISSNe">1460-2385</idno>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2558" to="2566" />
			<date type="published" when="2011-01-10" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Smoking is a risk factor in the progression to kidney failure</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stein</forename><forename type="middle">I</forename><surname>Hallan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephan</forename><forename type="middle">R</forename><surname>Orth</surname></persName>
		</author>
		<idno type="DOI">10.1038/ki.2011.157</idno>
		<idno type="PMID">21677635</idno>
	</analytic>
	<monogr>
		<title level="j">Kidney International</title>
		<title level="j" type="abbrev">Kidney International</title>
		<idno type="ISSN">0085-2538</idno>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="516" to="523" />
			<date type="published" when="2011-09" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Association between smoking and chronic kidney disease: a case control study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rabi</forename><surname>Yacoub</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Habib</forename><surname>Habib</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ayham</forename><surname>Lahdo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Radwan</forename><surname>Al Ali</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Leon</forename><surname>Varjabedian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">George</forename><surname>Atalla</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nader</forename><surname>Kassis Akl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Saleem</forename><surname>Aldakheel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Saeed</forename><surname>Alahdab</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sami</forename><surname>Albitar</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2458-10-731</idno>
		<idno type="PMID">21108832</idno>
		<idno type="PMCID">PMC3004836</idno>
		<ptr type="open-access" target="https://bmcpublichealth.biomedcentral.com/track/pdf/10.1186/1471-2458-10-731" />
	</analytic>
	<monogr>
		<title level="j">BMC Public Health</title>
		<title level="j" type="abbrev">BMC Public Health</title>
		<idno type="ISSNe">1471-2458</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="731" to="736" />
			<date type="published" when="2010-11-25" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">A study of patients with diabetes mellitus (type 1) and end-stage renal failure: tobacco usage may increase risk of nephropathy and death</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">G</forename><surname>Stegmayr</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1365-2796.1990.tb00204.x</idno>
		<idno type="PMID">2394962</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Internal Medicine</title>
		<idno type="ISSN">0954-6820</idno>
		<idno type="ISSNe">1365-2796</idno>
		<imprint>
			<biblScope unit="volume">228</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="121" to="124" />
			<date type="published" when="1990-08" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">M</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Studenski</surname></persName>
		</author>
		<idno type="DOI">10.1001/archinte.152.10.2082</idno>
		<idno type="PMID">1417382</idno>
	</analytic>
	<monogr>
		<title level="j">Archives of Internal Medicine</title>
		<idno type="ISSN">0003-9926</idno>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2082" to="2088" />
			<date type="published" when="1992-10-01" />
			<publisher>American Medical Association (AMA)</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
